NCT07106372View on ClinicalTrials.gov

A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

June 30, 2027

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

Stapokibatrt

Stapokibatrt Subcutaneous injection

Trial Locations (1)

Unknown

Beijing Children's Hospital Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT07106372 - A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter